Spreading the word about GORD

Considering the key factors involved in proton pump Inhibitor therapy may assist pharmacists in initiating successful step-down attempts Gastro-oesophageal reflux disease (GORD) is a common complaint among the general community. Despite the lack of data on the prevalence of the disease in Australia, it’s estimated to affect anywhere between 10–15% of the population. While heartburn